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B A C K G R O U N D  
Establishing the prevalence in the UK of multiple 
sclerosis (MS) among ethnic minorities hailing from 
low prevalence countries is of interest to explore 
factors involved in MS causation. East London is 
home to an ethnically diverse population, thus 
providing an excellent backdrop to update 
previously reported prevalence data [1]. Real-time 
prevalence data derived from primary care in East 
London were used.
R E S U L T S  
A total of 907,151 patients were 
registered with GP practices in East 
London. Of these, 776 had a diagnosis of 
MS. The table below shows a breakdown 
of this MS population by sex and 
ethnicity.  
Overall MS prevalence was 111/100,000 
(152 for women, 70 for men).  
Prevalence was 180, 74, and 29 for the 
White, Black and South Asian 
populations, respectively. The 
female:male ratio was 2.2:1, 2.1:1 and 
2.8:1, respectively. The bar-chart 
illustrates the sex and ethnic- specific 
prevalence rates.
Ethnicity and Multiple Sclerosis Prevalence in East London 
Christo Albor, Tim du Sautoy, Narmadha Kali Vanan, Kambiz Boomla, and Klaus Schmierer 
Contact: c.albor@qmul.ac.uk 
This work has been supported by a non-restricted educational grant from Novartis.
Sex and Ethnic-specific MS Prevalence (per 100K)
50
100
150
200
250
300
Female Male
1543 48
100 113
247
White
Black
South Asian
D I S C U S S I O N  
Compared to the White population MS prevalence 
remains considerably lower amongst Black and 
South Asian people, by 59% and 84%, respectively.  
However, compared to available data in Africa and 
South Asia, MS is up to 10 times (or more) 
prevalent among Blacks and South Asians living in 
the UK than their territorial ancestry [3].  
Whilst this difference may partly be explained by 
under-diagnosis and under-reporting the 
magnitude of the increase in risk suggests an 
important role of an environmental agent (or 
several thereof). As we were not (yet) in the 
position to separate minorities born in the UK from 
those born abroad, no definitive conclusions can 
be drawn at this stage.  
Despite general agreement of our estimates with 
previous studies in the UK, we detected an 
important difference: whilst previously Black 
people were found to have the lowest MS risk [1], 
in our study their risk was second only to White 
people. The rise of MS among Black people 
warrants further research, though in the UK Black 
people are far from ‘overtaking’ the White 
population as has been reported in two studies 
from the US [2].
No. people with MS in East London
Female Male Total  (%)
White 345 162 507 (65)
Black 77 34 111 (14)
South Asian 47 24 71 (9)
Other 15 9 24 (3)
Unknown 38 25 63 (8)
Total 522 254 776
M E T H O D S  
We studied the population residing in the four 
London boroughs closest to The Royal London 
Hospital (Barts Health NHS Trust), where our MS 
services are based. These boroughs, highlighted in 
yellow above, are Tower Hamlets, Newham, Hackney, 
and the City. For simplicity, we refer to these 
boroughs together as ‘East London’.  
Electronic records from GPs in these boroughs were 
queried  from a 2014 extract of a primary  care 
records database provided by the Clinical 
Effectiveness Group at the Centre for Primary Care 
(Blizard Institute). From this we derived the number 
of patients in East London with a diagnosis of MS, 
grouped by ethnicity and into 5-year age brackets.  
We derived the total number of people registered 
with GPs in East London in the same way. We then 
calculated the age-standardised MS prevalence, for 
the total population, and separately for White, Black 
and South Asian populations. Age-standardisation 
followed the direct method based on the 2013 
European Standard Population.
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